阿尔茨海默病的治疗方法。对有前景的药物发现策略的非正式调查。 - Suppr | 超能文献

Therapeutic approaches to Alzheimer's disease. An informal survey of promising drug discovery strategies.

作者信息

Schehr R S

出版信息

Biotechnology (N Y). 1994 Feb;12(2):140-4. doi: 10.1038/nbt0294-140.

DOI:10.1038/nbt0294-140

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Therapeutic approaches to Alzheimer's disease. An informal survey of promising drug discovery strategies.阿尔茨海默病的治疗方法。对有前景的药物发现策略的非正式调查。

Biotechnology (N Y). 1994 Feb;12(2):140-4. doi: 10.1038/nbt0294-140.

2

Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.用于阿尔茨海默病的基于他克林的多功能药物：持续发展中的一个古老故事§

Curr Med Chem. 2017;24(32):3522-3546. doi: 10.2174/0929867324666170309123920.

3

Development of memory-enhancing agents in the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的记忆增强剂的研发。

J Am Geriatr Soc. 1987 Oct;35(10):957-8. doi: 10.1111/j.1532-5415.1987.tb02298.x.

4

Tacrine derivatives and Alzheimer's disease.他克林衍生物与老年痴呆症。

Curr Med Chem. 2010;17(17):1825-38. doi: 10.2174/092986710791111206.

5

Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.他克林-石杉碱甲杂合物（石杉碱类）：一类新型高效且具有选择性的乙酰胆碱酯酶抑制剂，有望用于治疗阿尔茨海默病。

Mini Rev Med Chem. 2001 Jul;1(2):163-74. doi: 10.2174/1389557013406972.

6

Design of new drugs for the treatment of Alzheimer's disease based on tacrine structure.基于他克林结构设计用于治疗阿尔茨海默病的新药。

Curr Drug Targets. 2013 Mar;14(3):378-97. doi: 10.2174/138945013804999043.

7

Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines.他克林类药物作为阿尔茨海默病的治疗药物。四、他克林吡啶类及相关稠合他克林。

Chem Rec. 2019 May;19(5):927-937. doi: 10.1002/tcr.201800155. Epub 2018 Nov 29.

8

Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease.他克林的羟基化代谢产物在药物毒性及阿尔茨海默病治疗中的可能作用。

Curr Drug Metab. 2008 May;9(4):332-5. doi: 10.2174/138920008784220619.

9

Alzheimer's disease and caregiver time.阿尔茨海默病与照顾者时间

Lancet. 1994 Jan 22;343(8891):239-40. doi: 10.1016/s0140-6736(94)91027-8.

10

Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD.多功能他克林衍生物针对阿尔茨海默病多种疾病途径的合成与药理评价

Bioorg Med Chem Lett. 2015 Feb 15;25(4):807-10. doi: 10.1016/j.bmcl.2014.12.084. Epub 2015 Jan 6.

引用本文的文献

1

Potential role of muscarinic agonists in Alzheimer's disease.毒蕈碱激动剂在阿尔茨海默病中的潜在作用。

Drugs Aging. 1997 Dec;11(6):450-9. doi: 10.2165/00002512-199711060-00004.

2

The solubilization of model Alzheimer tangles: reversing the beta-sheet conformation induced by aluminum with silicates.模型阿尔茨海默氏缠结的溶解：用硅酸盐逆转铝诱导的β-折叠构象。

Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11232-5. doi: 10.1073/pnas.91.23.11232.

3

Solubilization of beta-amyloid-(1-42)-peptide: reversing the beta-sheet conformation induced by aluminum with silicates.β-淀粉样蛋白（1-42）肽的增溶作用：用硅酸盐逆转铝诱导的β-折叠构象。

Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):369-71. doi: 10.1073/pnas.92.2.369.